In the same manner, are recently reported results combining anti-PD-1 and anti-CTLA-4 checkpoint inhibitors with pharmacological inhibition of PAD4 in a syngeneic mouse model of breast cancer and metastasis based on subcutaneous and intravenously injected 4 T1 cells [42]. The gene discussed is PADI4; the disease is breast carcinoma.